Roger Song
Stock Analyst at Jefferies
(0.81)
# 3,730
Out of 4,843 analysts
46
Total ratings
28.95%
Success rate
-23.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $40 → $45 | $27.19 | +65.53% | 2 | Apr 29, 2025 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | $1 → $2 | $0.74 | +170.49% | 11 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Initiates: Buy | $6 | $3.01 | +99.34% | 1 | Apr 1, 2025 | |
| SANA Sana Biotechnology | Initiates: Buy | $7 | $2.27 | +208.37% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $125.61 | +95.05% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $6.24 | +316.67% | 1 | Feb 25, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.33 | +50.38% | 2 | Jan 10, 2025 | |
| BIOA BioAge Labs | Downgrades: Hold | $42 → $7 | $3.98 | +76.10% | 2 | Dec 9, 2024 | |
| REPL Replimune Group | Maintains: Buy | $16 → $19 | $9.37 | +102.77% | 1 | Dec 4, 2024 | |
| KURA Kura Oncology | Maintains: Buy | $32 → $28 | $5.82 | +381.10% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $7 | $1.46 | +379.45% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $46.87 | +89.89% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $7.19 | +247.71% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $10.64 | +285.34% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $10.00 | +250.00% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.26 | +111.52% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $32.80 | +293.29% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $2.52 | +217.46% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $74.79 | +29.70% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $16.51 | +336.10% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $28.16 | +290.63% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $5.61 | +523.89% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.90 | +897.89% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $3.81 | +110.25% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $0.21 | +1,776.17% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.90 | +2,233.33% | 1 | Sep 2, 2020 |
Kiniksa Pharmaceuticals International,
Apr 29, 2025
Maintains: Buy
Price Target: $40 → $45
Current: $27.19
Upside: +65.53%
Nektar Therapeutics
Apr 11, 2025
Upgrades: Buy
Price Target: $1 → $2
Current: $0.74
Upside: +170.49%
Akebia Therapeutics
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $3.01
Upside: +99.34%
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $2.27
Upside: +208.37%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $125.61
Upside: +95.05%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $6.24
Upside: +316.67%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.33
Upside: +50.38%
BioAge Labs
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $3.98
Upside: +76.10%
Replimune Group
Dec 4, 2024
Maintains: Buy
Price Target: $16 → $19
Current: $9.37
Upside: +102.77%
Kura Oncology
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $5.82
Upside: +381.10%
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.46
Upside: +379.45%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $46.87
Upside: +89.89%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $7.19
Upside: +247.71%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $10.64
Upside: +285.34%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $10.00
Upside: +250.00%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $4.26
Upside: +111.52%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $32.80
Upside: +293.29%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $2.52
Upside: +217.46%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $74.79
Upside: +29.70%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $16.51
Upside: +336.10%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $28.16
Upside: +290.63%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $5.61
Upside: +523.89%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.90
Upside: +897.89%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $3.81
Upside: +110.25%
Nov 12, 2021
Upgrades: Buy
Price Target: $3 → $4
Current: $0.21
Upside: +1,776.17%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.90
Upside: +2,233.33%